Plasma endothelin-1 level in chronic obstructive pulmonary disease: Relationship with natriuretic peptide

Respiration

Volumn 66, Issue 3, 1999, Pages 212-219

  Fujii, Tatsuo ^a   Otsuka, Toshihiro ^a   Tanaka, Shigehiro ^a   Kanazawa, Hiroshi ^a   Hirata, Kazuto ^a   Kohno, Masakazu ^a   Kurihara, Naotsugu ^a   Yoshikawa, Junichi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atrial natriuretic peptide; Brain natriuretic peptide; Chronic obstructive pulmonary disease; Endothelin 1; Hypoxemia; Pulmonary hypertension

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; ENDOTHELIN 1; OXYGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; HEART CATHETERIZATION; HUMAN; HYPOXEMIA; MALE; OXYGEN BREATHING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VENOUS OXYGEN TENSION;

AGED; ANOXEMIA; ATRIAL NATRIURETIC FACTOR; ENDOTHELIN-1; EXERCISE; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; REFERENCE VALUES;

EID: 0033040786     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029380     Document Type: Article

References (37)

1. Magee F, Wright JL, Wiggs BR, Pare PD, Hogg JC: Pulmonary vascular structure and function in chronic obstructive pulmonary disease. Thorax 1988;43:183-189.
2. Burrows B, Kettel LJ, Niden AH, Rabinowitz M, Diener CF: Patterns of cardiovascular dysfunction in chronic obstructive lung disease. N Engl J Med 1972;286:912-918.
3. Mahler DA, Brent BN, Loke J, Zaret BL, Matthay RA: Right ventricular performance and central circulatory hemodynamics during upright exercise in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1984;130:722-729.
4. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
5. Ando K, Hirata Y, Shichiri M, Emori T, Marumo F: Presence of immunoreactive endothelin in human plasma. FEBS Lett 1989;245:164-166.
6. Miyauchi T, Yanagisawa M, Tomizawa T, Sugishita Y, Suzuki N, Fujino M, Ajisaka R, Goto K., Masaki T: Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet 1989;ii:53-54.
7. Luscher TF, Boulanger CM, Dohi Y, Yang Z: Endothelium-derived contracting factors. Hypertension 1992;19:117-130.
8. Kohno M, Yasunari K, Murakawa K, Yokokawa K, Horio T, Fukui T, Takeda T: Plasma immunoreactive endothelin in essential hypertension. Am J Med 1990;88:614-618.
9. Stewart DJ, Levy RD, Cemacek P, Langleben D: Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease? Ann Intern Med 1991;114:464-469.
10. Ferri C, Bellini C, Angelis CD, Siati LD, Perrone A, Properzi G, Santucci A: Circulating endothelin-1 concentrations in patients with chronic hypoxia. J Clin Pathol 1995;48:519-524.
11. Cargill RI, Kiely DG, Clark RA, Lipworth BJ: Hypoxaemia and release of endothelin-1. Thorax 1995;50:1308-1310.
12. 2 removal and to hyperoxia. Am Rev Respir Dis 1990;141:1178-1184.
13. Lang CC, Coutie WJ, Struthers AD, Dhillon DP, Winter JH, Lipworth BJ: Elevated levels of brain natriuretic peptide in acute hypoxaemic chronic obstructive pulmonary disease. Clin Sci 1992;83:529-533.
14. Saijonmaa O, Ristimaki A, Fyhrquist F: Atrial natriuretic peptide, nitroglycerine, and nitro-prusside reduce basal and stimulated endothelin production from cultured endothelial cells. Biochem Biophys Res Commun 1990;173: 514-520.
15. Kohno M, Yasunari K, Yokokawa K, Murakawa K, Horio T, Takeda T: Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin II and thrombin of cultured human endothelial cells. J Clin Invest 1991;87:1999-2004.
16. Kohno M, Yasunari K, Matsuura T, Murakawa K, Takeda T: Circulating atrial natriuretic polypeptide in essential hypertension. Am Heart J 1987;113:1160-1163.
17. Kohno M, Horio T, Yokokawa K, Murakawa K, Yasunari K, Akioka K, Tahara A, Toda I, Takeuchi K, Kurihara N, Takeda T: Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 1992;92:29-34.
18. Komuro I, Kurihara H, Sugiyama T, Takaku F, Yazaki Y: Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 1988;238:249-252.
19. Hirata Y, Takagi Y, Fukuda Y, Marumo F: Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 1989;78: 225-228.
20. Janakidevi K, Fisher MA, Del Vecchio PJ, Tiruppathi C, Figge J, Malik AB: Endothelin-1 stimulates DNA synthesis and proliferation of pulmonary artery smooth muscle cells. Am J Physiol 1992;263:C1295-C1301.
21. Currie MG, Geller DM, Cole BR, Boylan JG, Yu Sheng W, Holmberg SW, Needleman P: Bioactive cardiac substances: Potent vasorelaxant activity in mammalian atria. Science 1983; 221:71-73.
22. Winquist RJ, Faison EP, Nutt RF: Vasodilator profile of synthetic atrial natriuretic factor. Eur J Pharmacol 1984;102:169-173.
23. Sudoh T, Kangawa K, Minamino N, Matsuo H: A new natriuretic peptide in porcine brain. Nature 1988;332:78-81.
24. Mcgregor A, Richard M, Espiner E, Yandle T, Ikaram H: Brain natriuretic peptide administration to man: Actions and metabolism. J Clin Endocrinol Metab 1990;70:1103-1107.
25. Zhao L, Winter RJD, Krausz T, Hughes JMB: Effects of continuous infusion of atrial natriuretic peptide on the pulmonary hypertension induced by chronic hypoxia in rats. Clin Sci 1991;81:379-385.
26. Ou LC, Sardella GL, Hill NS, Thron CD: Does atrial natriuretic factor protect against right ventricular overload? I. Hemodynamic study. J Appl Physiol 1989;67:1606-1611.
27. Zhao L, Hughes JMB, Winter RJD: Effects of natriuretic peptides and neutral endopeptidase 24.11 inhibition in isolated perfused rat lung. Am Rev Respir Dis 1992;146:1198-1201.
28. Yoszhizumi M, Kurihara H, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, Yazaki Y: Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells. Biochem Biophys Res Commun 1989;161: 859-864.
29. Rakugi H, Tabuchi Y, Nakamaru M, Nagano M, Higashimori K, Mikami H, Ogihara T: Evidence for endothelin-1 release from resistance vessels of rats in response to hypoxia. Biochem Biophys Res Commun 1990;169:973-977.
30. Kourembanas S, Marsden PA, McQuillan LP, Faller DV: Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 1991;88:1054-1057.
31. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ, Schneider B, Waldhausl W, Binder BR: Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 1992;267:16066-16068.
32. Goerre S, Wenk M, Bartsch P, Luscher TF, Niroomand F, Hohenhaus E, Oelz O, Reinhart WH: Endothelin-1 in pulmonary hypertension associated with high-altitude exposure. Circulation 1995;90:359-364.
33. Minh VD, Lee HM, Dolan GF, Light RW, Bell J, Vasquez P: Hypoxemia during exercise in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1979;120:787-794.
34. Deleuze PH, Adnot S, Shiiya N, Thoraval R, Eddahibi S, Braquet P, Chabrier PE, Loisance DY: Endothelin dilates bovine pulmonary circulation and reverses hypoxic pulmonary vaso-constriction. J Cardiovasc Pharmacol 1992;19: 354-360.
35. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T: Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990;348:732-735.
36. Vane J: Endothelins come home to roost. Nature 1990;348:673-675.
37. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S: Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990; 348:730-732.